Covıd-19, Coronavirus, Germany, Vaccine

Covıd-19, Coronavirus

German-Chinese coronavirus vaccine trial begins in China

German-Chinese coronavirus vaccine trial begins in China

5/8/2020 3:15:00 PM

German-Chinese coronavirus vaccine trial begins in China

BERLIN: Clinical trials on humans have begun in China for a potential coronavirus vaccine developed by German pharmaceutical group BioNTech with ...

BookmarkBERLIN: Clinical trials on humans have begun in China for a potential coronavirus vaccine developed by German pharmaceutical group BioNTech with Chinese company Fosun Pharma, the companies said Wednesday (Aug 5).Seventy-two participants have already received their first dose following approval for the phase 1 trial from Chinese regulatory authorities, BioNTech and Fosun Pharma said in a statement.

Tighter COVID-19 measures important as Singapore is on a 'knife’s edge': Lawrence Wong 13 new community COVID-19 cases, including 7 linked to Changi Airport cluster Police arrest man who allegedly used racial slurs, kicked woman in Choa Chu Kang

AdvertisementAdvertisementThe vaccine candidate, known as BNT162b1, is one of four based on BioNTech's proprietary mRNA technology.Another, BNT162b2, is being evaluated in a global phase 3 trial conducted by BioNTech and US giant Pfizer which started on Jul 27.

The phase 1 trial in China involves 144 participants who will receive two doses 21 days apart.Those aged 18-55 will be the first to take part, followed by older people.AdvertisementAdvertisementLaboratories around the world are racing to find a vaccine to curb COVID-19, which has claimed more than 700,000 lives and upended the livelihoods of millions. headtopics.com

More than 200 candidate vaccines are currently being developed with roughly two dozen at the stage of clinical trials with human volunteers.Several Chinese companies are at the forefront of the global vaccine race, while Russia has said it hopes to be the first in the world to produce a vaccine for the public, with a target date of September.

But the medicines will likely face heightened scrutiny given that the regulatory systems in both countries are far more opaque than they are in the West. Read more: CNA »

Singapore returns to tighter COVID-19 measures: What's allowed under the new rules?

SINGAPORE: With the recent rise in COVID-19 cases in the community, Singapore has announced tighter measures for about three weeks from Saturday ...

China will retaliate if Chinese journalists in US forced out: Global Times editorSHANGHAI: China will take retaliatory measures should all Chinese journalists based in the United States be forced to leave the country, including ...

China will retaliate if Chinese journalists in US forced outSHANGHAI (REUTERS) - China will take retaliatory measures should all Chinese journalists based in the United States be forced to leave the country, including targeting US journalists in Hong Kong, Global Times Editor in Chief Hu Xijin said on Tuesday (Aug 4).. Read more at straitstimes.com.

China will not accept US 'theft' of TikTok: China DailySHANGHAI (REUTERS) - China will not accept the 'theft' of a Chinese technology company and is able to respond to Washington's move to push ByteDance to sell short-video app TikTok's US operations to Microsoft, the China Daily newspaper said on Tuesday (Aug 4).. Read more at straitstimes.com.

China will not accept US 'theft' of TikTok: China DailyThe United States' 'bullying' of Chinese tech companies was a consequence of Washington's zero-sum vision of 'American first' and left China no ...

China will not accept U.S. 'theft' of TikTok: China DailyChina will not accept the 'theft' of a Chinese technology company and is able to respond to Washington's move to push ByteDance to sell short-video app TikTok's U.S. operations to Microsoft, the China Daily newspaper said on Tuesday. The United States' 'bullying' of Chinese

'Permanent risk of infection': German basketballer sacked after demo visit Germany basketball international Joshiko Saibou was sacked by his club Baskets Bonn on Tuesday after he attended a demonstration in Berlin last ...